SEARCH · PubMed Health

Results for “validity”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5Linked to original sources

PubMed2003

Estimating the validity of the guilty knowledge test from simulated experiments: the external validity of mock crime studies.

This experiment was designed to examine the external validity of the standard mock-crime procedure used extensively to evaluate the validity of polygraph tests. The authors manipulated the type of mock-crime procedure (standard vs. a more realistic version) and the time of test (immediate vs. delayed) and examined their effects on the validity of the Guilty Knowledge Test (GKT) and the recall rate of the relevant items. The results indicated that only the type of mock-crime affected the 2 outcome variables. The realistic procedure was associated with a lower recall rate and weaker detection efficiency than the standard procedure. However, these effects were mediated by the type of GKT questions used. Practical implications of these results are discussed.

Adult↗

PubMed1988

Retaining qualitative validity while gaining quantitative reliability and validity: development of the Transition to Parenthood Concerns Scale.

This article raises issues about the retention of qualitative validity while establishing psychometric estimates of reliability and validity for a scale that was developed from inductively generated concepts to assess and evaluate the learning needs and concerns of expectant parents in the trimester before their baby's birth. A set of practical procedures for pilot testing qualitatively based scales is described. The three procedures, which provide estimates of clarity, apparent internal consistency, and content validity, preserve the assumptions underlying qualitative methods. The ratings from these procedures have provided a base for item and scale revisions and formal quantitative testing.

Adult↗

PubMed2003

Validation of the TONOPORT V ambulatory blood pressure monitor according to the European Society of Hypertension International Protocol for Validation of Blood Pressure Measuring Devices in Adults.

BACKGROUND: It is now accepted that blood pressure measuring devices should be subjected to an independent evaluation of their accuracy before they are marketed for clinical use. The results of validation of the TONOPORT V blood pressure monitor for the measurement of ambulatory blood pressure according to the European Society of Hypertension International Protocol for Validation of Blood Pressure Measuring Devices in Adults are presented in this paper. POPULATION: Thirty-three subjects were recruited from among staff and patients at Beaumont Hospital, Dublin, Ireland. METHODS: The TONOPORT V monitor was connected to the Sphygmocorder, an audiovisual system for validation, which records blood pressure on tape and video for later analysis. Nine sequential same-arm measurements between the device and a standard mercury sphygmomanometer were recorded using the Sphygmocorder. RESULTS: In phase 1, the TONOPORT V monitor produced 28 measurements within 5 mmHg, 37 within 10 mmHg and 40 within 15 mmHg for systolic blood pressure (SBP), and 26 within 5 mmHg, 38 within 10 mmHg and 44 within 15 mmHg for diastolic blood pressure (DBP). The mean differences were -2.2 (8.6) [mean (SD)] mmHg for SBP and +0.5 (7.2) mmHg for DBP. The TONOPORT V monitor passed all the criteria for both SBP and DBP. In phase 2.1, the TONOPORT V monitor had 56 measurements within 5 mmHg, 78 within 10 mmHg and 88 within 15 mmHg for SBP, and 60 measurements within 5 mmHg, 83 within 10 mmHg and 97 within 15 mmHg for DBP. The mean differences were -1.4 (8.7) mmHg for SBP and -0.2 (6.8) mmHg for DBP. The TONOPORT V monitor passed the criteria for DBP but failed to meet any of the criteria for SBP. In phase 2.2, 19 subjects had at least two of the differences within 5 mmHg and six subjects had no differences within 5 mmHg for SBP, and 22 subjects had at least two of the differences within 5 mmHg and six subjects no differences within 5 mmHg for DBP. The TONOPORT V monitor failed to meet the criteria for SBP and for DBP. CONCLUSIONS: The TONOPORT V monitor cannot be recommended for clinical use in an adult population because it records SBP inaccurately and because it records DBP inaccurately in an unacceptably high proportion of people.

Adult↗

PubMed2003

Validation of the ROSSMAX blood pressure measuring monitor according to the European Society of Hypertension International Protocol for Validation of Blood Pressure Measuring Devices in Adults.

BACKGROUND: It is now accepted that blood pressure measuring devices should be subjected to an independent evaluation of their accuracy before they are marketed for clinical use. The results of validation of the ROSSMAX Blood Pressure Measuring Monitor for self-measurement according to the European Society of Hypertension International Protocol for Validation of Blood Pressure Measuring Devices in Adults are presented in this paper. POPULATION: Thirty-three subjects were recruited from among staff and patients at Beaumont Hospital, Dublin, Ireland. METHODS: The ROSSMAX monitor was connected to the Sphygmocorder, an audiovisual system for validation, which records blood pressure on tape and video for later analysis. Nine sequential same-arm measurements between the device and a standard mercury sphygmomanometer were recorded using the Sphygmocorder. RESULTS: In phase 1, the ROSSMAX monitor produced 21 measurements within 5 mmHg, 31 within 10 mmHg and 38 within 15 mmHg for systolic blood pressure (SBP), and 36 within 5 mmHg, 43 within 10 mmHg and 45 within 15 mmHg for diastolic blood pressure (DBP). The mean differences were -5.6 (10.2) [mean (SD)] mmHg for SBP and -0.5 (4.5) mmHg for DBP. The ROSSMAX monitor failed to meet any of the criteria for SBP but comfortably passed all of the criteria for DBP. In phase 2.1, the ROSSMAX monitor had 51 measurements within 5 mmHg, 73 within 10 mmHg and 86 within 15 mmHg for SBP, and 71 measurements within 5 mmHg, 93 within 10 mmHg and 98 within 15 mmHg for DBP. The mean differences were -4.5. (9.5) mmHg for SBP and -1.8 (5.0) mmHg for DBP. The ROSSMAX monitor failed to meet any of the criteria for SBP but comfortably passed all of the criteria for DBP. In phase 2.2, 16 subjects had at least two of the differences lying within 5 mmHg and 10 subjects had no differences within 5 mmHg for SBP; 26 subjects had at least two of the differences falling within 5 mmHg and three subjects no differences within 5 mmHg for DBP. The ROSSMAX monitor failed to meet the criteria for SBP but passed the criteria for DBP. CONCLUSIONS: The ROSSMAX monitor cannot be recommended for clinical use in an adult population because it records SBP inaccurately.

Adult↗

PubMed2004

Validation of the OSCAR 2 oscillometric 24-hour ambulatory blood pressure monitor according to the International Protocol for the validation of blood pressure measuring devices.

OBJECTIVES: The accuracy of blood pressure measuring devices is of prime importance and should be validated before devices are used clinically. We carried out an independent evaluation of the OSCAR 2 oscillometric ambulatory blood pressure monitor (SunTech Medical model 222) according to the European Society of Hypertension International Protocol. METHODS: Adult subjects were recruited from patients and staff at The James Cook University Hospital, Middlesbrough, UK. Nine sequential same-arm blood pressure measurements were taken alternating between simultaneous readings by two independent, trained observers using mercury sphygmomanometers and the device operated by a third observer. In phase one, 15 subjects participated (five in each of the low, medium and high blood pressure ranges) with 18 subjects participating in phase two. Data from 33 subjects (11 in each of the three blood pressure ranges) were analysed for systolic (19 male, 14 female, mean age 56.0 years) and for diastolic (17 male, 16 female, mean age 51.1 years) blood pressure. RESULTS: The OSCAR 2 passed the first phase of the validation process. In phase 2.1, the OSCAR 2 monitor had 71 readings within 5 mmHg, 86 within 10 mmHg and 94 within 15 mmHg for systolic blood pressure (SBP) and 72 readings within 5 mmHg, 88 within 10 mmHg and 96 within 15 mmHg for diastolic blood pressure (DBP). Mean (+/-SD) differences between observers and device were 0.9+/-2.3 mmHg for SBP and -0.5+/-2.3 mmHg for DBP. In phase 2, 24 subjects had at least two of the differences within 5 mmHg and three subjects had no differences within 5 mmHg for SBP while for DBP 25 subjects had at least two of the differences within 5 mmHg and two subjects had no differences within 5 mmHg. CONCLUSIONS: The OSCAR 2 passes all requirements for validation by the International Protocol and can be recommended for clinical use in an adult population.

Adult↗

PubMed2004

French version of the addiction severity index (5th Edition): validity and reliability among Swiss opiate-dependent patients. French validation of the Addiction Severity Index.

OBJECTIVE: The aim of the study was to validate a French adaptation of the 5th version of the Addiction Severity Index (ASI) instrument in a Swiss sample of illicit drug users. PARTICIPANTS AND SETTING: The participants in the study were 54 French-speaking dependent patients, most of them with opiates as the drug of first choice. PROCEDURE: Analyses of internal consistency (convergent and discriminant validity) and reliability, including measures of test-retest and inter-observer correlations, were conducted. RESULTS: Besides good applicability of the test, the results on composite scores (CSs) indicate comparable results to those obtained in a sample of American opiate-dependent patients. Across the seven dimensions of the ASI, Cronbach's alpha ranged from 0.42 to 0.76, test-retest correlations coefficients ranged from 0.48 to 0.98, while for CSs, inter-observer correlations ranged from 0.76 to 0.99. CONCLUSIONS: Despite several limitations, the French version of the ASI presents acceptable criteria of applicability, validity and reliability in a sample of drug-dependent patients.

Adult↗

PubMed1996

MCMI-III diagnostic validity: bad test or bad validity study.

Operating characteristics describe the validity of tests that attempt to dichotomously predict a diagnosis. These statistics are not fully published in the Millon Clinical Multiaxial Inventory-III Manual (MCMI-III manual; Millon, 1994). When calculated from available statistics, the positive predictive powers of the MCMI-III scales are poor both in absolute terms and relative to the MCMI-II (Millon, 1987). There were a number of problems, however, with the initial MCMI-III validity study both inherently and in execution. Although it is doubtful that the MCMI-III is weaker than the MCMI-II, a new validity study is needed.

Diagnosis, Differential↗

PubMed1995

Competency-Based Certification Project. Phase III: content validity, standard setting and criterion-related validity.

This is the final article in a three-part series explaining the CAMRT's Competency-Based Certification Project--an effort to make the Association's certification process more job-relevant. The first article (Journal, August 1994) explained the job analysis process used to specify and validate the list of duties and tasks required of entry-level medical radiation technologists, the imaging and treatment procedures they perform, and the equipment they use. The second article (Journal, October 1994) explained the process for developing an examination blueprint by reviewing the CAMRT's examinations and summaries of clinical experience in the context of competency-based evaluation and the job analysis validation in each discipline. This article examines the development of assessment standards for certification examinations and summaries of clinical experience. It provides an overview of the steps necessary to develop a valid and defensible licensure/certification process after development of the examination content is complete.

Canada↗

PubMed1998

Validation of the Omron F3 blood pressure measuring device for use in the finger through simultaneous invasive comparative measurements according to the German Institute for Validation (DIN) 58130 protocol.

OBJECTIVES AND DESIGN: Simultaneous invasive comparative measurements in order to validate the blood pressure measuring device Omron F3 for use in the finger, in accordance with the German Institute for Validation (DIN) 58130 protocol. METHODS: A total of five consecutive simultaneous blood pressure comparative measurements were carried out in each of 15 patients (n = 75). Blood pressure was measured in the left index finger using the blood pressure measuring device Omron F3, and at the same time invasively using a pigtail catheter situated in the aortic arch. The measuring arrangements, validation of the unit of invasive measurement and evaluation were all carried out in accordance with the DIN 58130 protocol. RESULTS: The blood pressure measuring device Omron F3 for use in the finger fulfils the criteria of the European Standard prEn 1060-3. Systolic blood pressure decreased by 2.9+/- 6.6 mmHg and diastolic blood pressure decreased by 2.6+/- 5.9 mmHg. CONCLUSION: The blood pressure measuring device Omron F3 measures blood pressure reliably and accurately if used correctly in appropriate patients. Before using the device for the first time, comparative blood pressure measurements in the upper arm, using the standard auscultatory blood pressure measurement technique according to Riva-Rocci and Korotkoff, should be carried out, in order to check the accuracy of measurement.

Adult↗

PubMed1997

Validation of the OMRON R3 blood pressure self-measuring device through simultaneous comparative invasive measurements according to protocol 58130 of the German Institute for Validation.

OBJECTIVES: To perform simultaneous invasive comparative measurements in order to validate the blood pressure self-measuring device OMRON R3 for use on the wrist, in accordance with protocol 58130 of the German Institute for Validation. METHODS: Five consecutive comparative blood pressure measurements were carried out for each of 15 patients (n = 75 measurements). The blood pressure was measured simultaneously non-invasively using the blood pressure self-measuring device OMRON R3 around the left wrist and at the same time invasively using a pigtail catheter situated in the aortic arch. The pressure curves were drawn continuously. The measuring arrangements, validation of the invasive-measurement unit and evaluation were all carried out in accordance with protocol 58130. RESULTS: The blood pressure self-measuring device OMRON R3 for use on the wrist satisfied the criteria of the European Standard prEn 1060-3. The OMRON systolic values were 2.2 +/- 3.9 mmHg higher and the diastolic values were 0.2 +/- 2.7 mmHg lower than the invasive ones. However, for higher blood pressure levels (> 150 mmHg), the device tested displayed an increasing tendency to underestimate the systolic blood pressure in one-third of the patients by 5-15 mmHg, compared with the invasive measurements. No faulty measurements occurred with the patient group examined. CONCLUSION: The blood pressure self-measuring device OMRON R3 for use on the wrist can be recommended for blood pressure self-measurement. When it is used correctly, it measures the blood pressure reliably and accurately.

Journal Article↗

PubMed2000

Bias and Sampling Error of the Estimated Proportion of Genotypic Variance Explained by Quantitative Trait Loci Determined From Experimental Data in Maize Using Cross Validation and Validation With Independent Samples.

Cross validation (CV) was used to analyze the effects of different environments and different genotypic samples on estimates of the proportion of genotypic variance explained by QTL (p). Testcrosses of 344 F(3) maize lines grown in four environments were evaluated for a number of agronomic traits. In each of 200 replicated CV runs, this data set was subdivided into an estimation set (ES) and various test sets (TS). ES were used to map QTL and estimate p for each run (p(ES)) and its median (p(ES)) across all runs. The bias of these estimates was assessed by comparison with the median (p(TS.ES)) obtained from TS. We also used two independent validation samples derived from the same cross for further comparison. The median p(ES) showed a large upward bias compared to p(TS.ES). Environmental sampling generally had a smaller effect on the bias of p(ES) than genotypic sampling or both factors simultaneously. In independent validation, p(TS.ES) was on average only 50% of p(ES). A wide range among p(ES) reflected a large sampling error of these estimates. QTL frequency distributions and comparison of estimated QTL effects indicated a low precision of QTL localization and an upward bias in the absolute values of estimated QTL effects from ES. CV with data from three QTL studies reported in the literature yielded similar results as those obtained with maize testcrosses. We therefore recommend CV for obtaining asymptotically unbiased estimates of p and consequently a realistic assessment of the prospects of MAS.

Journal Article↗

PubMed1991

Latent inhibition and blocking: further consideration of their construct validity as animal models of schizophrenia Commentary on Ellenbroek and Cools "Animal models with construct validity for schizophrenia"

Conventional animal models of schizophrenia do not pretend to account for the symptoms of schizophrenia; i.e. they lack construct validity. Ellenbroek and Cools (1990) have reviewed a number of other models with construct validity for fundamental psychological processes, which are hypothesised to be deficient in schizophrenia. Two of these, Latent Inhibition (LI) and the Kamin Blocking effect (KB), essentially demonstrate the effects of prior learning on the formation of current associations. Animal studies have now shown that LI and KB are disrupted by increased dopaminergic activity, and restored by dopaminergic blockade. The present paper adds to the database described by Ellenbroek and Cools and discusses some further theoretical and practical issues. Specifically: (a) Kamin's blocking is disrupted in acute, but not in chronic schizophrenic subjects; (b) LI and KB are not simply examples of associative interference; (c) The masking task used in adult human studies of LI does not introduce an element of blocking as defined by Kamin's paradigm; (d) A direct study of "selective attention" in acute schizophrenia suggests that the impairment in LI and KB relates to the utilisation of experience about past regularities, rather than a generalised attentional deficit; (e) Recent studies, especially with nicotine, indicate that LI can be disrupted by drug administration during acquisition only; (f) It is now possible to study the release of dopamine, and of other transmitters in the nucleus accumbens and in other brain areas, during the behavioural paradigm of LI in rats. In this way it should be possible to determine directly the neuronal circuitry involved in LI (and KB): this approach could explain the link between the neuropathology and neuropharmacology of schizophrenia and its symptoms, besides providing more valid test procedures for evaluating potential neuroleptic drugs.

Journal Article↗

PubMedDate not supplied

Ethical issues surrounding informed consent. Part II. Components of a morally valid consent and conditions that impair its validity.

To be valid, a consent must be given by a person who has received all relevant information, is competent, has not been coerced into agreement or refusal, and is not emotionally overwhelmed. Persons who have received incomplete information, are incompetent, have been coerced, or are psychodynamically overcome cannot give valid consent or refusal. HCPs who accept consents or refusals from such patients do not act in accordance with the ethical foundations and goals the practice was designed to promote. Nursing plays a crucial role in assuring the validity of informed consent/refusal. This role will be examined in Part III of this series.

Decision Making↗

PubMed2003

Validity and reliability of a virtual reality upper gastrointestinal simulator and cross validation using structured assessment of individual performance with video playback.

BACKGROUND: This study aims to evaluate the ability of an upper gastrointestinal virtual reality simulator to assess skills in endoscopy, and to validate its metrics using a video-endoscopic (VES) technique. METHODS: The 32 participants in this study were requested to undertake two cases on the simulator (Simbionix, Israel). Each module was repeated twice. The simulator's metrics of performance were used for analysis. two blinded observers rated performance watching the simulator's playback feature. RESULTS: There were 11 novices (group 1), 11 trainees with intermediate experience (10-50 procedures, group 2), and 10 experienced endoscopists (>200 procedures, group 3). There was a significant difference in the total time required to perform the procedure (p < 0.001), percentage of mucosa visualized (p < 0.001), percentage of pathologies visualized (p < 0.001), and number of inappropriate retroflexions (p = 0.015) across the three groups. The reliability of assessment on the simulator was greater than 0.80 for all parameters. The VES assessment also was able to discriminate performance across the groups (p < 0.001). There was a significant correlation between the VES score and the percentage of mucosa visualized (rho = 0.60; p < 0.001). CONCLUSIONS: The upper gastrointestinal simulator may be a useful tool for determining whether a trainee has achieved a desired level of competence in endoscopy. The next step will be to validate the VES score in real procedures.

Endoscopy, Gastrointestinal↗

PubMed2006

Validity and reliability of a quantitative food frequency questionnaire measuring n-3 fatty acid intakes in cardiac patients in the Midwest: a validation pilot study.

The purpose of this pilot study was to test the validity and reliability of a quantitative n-3 fatty acid food frequency questionnaire (FFQ) for later use with larger groups of individuals. A convenience sample of heart patients provided dietary data via three 24-hour food recalls and FFQs. Participants were women (n=17) and men (n=11), 43 to 77 years of age. The association of mean daily intake of n-3 fatty acids obtained using food recalls and the FFQ was assessed by Pearson correlation. The reliability of the FFQ was assessed using coefficient alpha. Correlation of n-3 fatty acid intake using the food recalls and the FFQ was r=0.42 (P<0.05). The coefficient alpha for the test-retest of the FFQ was .83. The top two foods, walnuts and flaxseed, contributed 58% of the n-3 fatty acid intake, and the third food, salmon, contributed 5%. This quantitative n-3 FFQ is a valid instrument for use in place of food recalls for estimating n-3 fatty acid intakes in heart patients and is a reliable instrument to estimate n-3 fatty acid intakes from plant, animal, and seafood sources. The FFQ should be tested in a larger population. Registered dietitians can use this FFQ to screen for intakes, educate patients on food sources, and measure change in intakes after nutrition intervention.

Adult↗

PubMed2002

The Religious Support Scale: construction, validation, and cross-validation.

Cutrona and Russell's social support model was used to develop a religious support measure (C. E. Cutrona & D. W. Russell, 1987), including 3 distinct but related subscales respectively measuring support from God, the congregation, and church leadership. Factor analyses with the main sample's data (249 Protestants) and cross-validation (93 additional Protestants) supported the scales' reliability and validity. All 3 types of religious support were related to lower depression and greater life satisfaction. Moreover, several relationships between the 3 subscales and psychological functioning variables remained significant after controlling for variance because of church attendance and social support. Results suggest that religious attendance does not automatically imply religious support, and that religious support can provide unique resources for religious persons, above and beyond those furnished by social support. Findings are discussed regarding relevance to community psychology.

Adult↗

PubMed2001

Validation of a nutrition screening tool: testing the reliability and validity.

BACKGROUND: The aim of this study was to validate a nutrition screening tool for use in South Manchester University Hospitals Trust. METHOD: A sample of 100 patients was selected from medical, surgical and elderly care wards. To test the reliability of the screening tool, nurses and dietitians completed the screening tool on the same patient. These results were compared for interobserver error to determine whether the screening tool was reproducible with different observers. To ascertain if the screening tool identified malnutrition at ward level, four markers commonly used to assess nutritional status were collected. These included body mass index (BMI), mid upper arm circumference MUAC, percentage weight loss, and energy intake calculated from the patient's first full day in hospital and expressed as a percentage of their estimated average requirements (EAR). RESULTS: There was a 95% level of agreement between nurses and dietitians within +/-3. The screening tool had a sensitivity level of 78% and a specificity of 52% when compared to all patients who had one or more markers indicating malnutrition. This association was found to be statistically significant (P < 0.005). CONCLUSION: The screening tool is reliable when completed by different observers and is valid for wide scale nutritional assessment. The screening tool identifies an acceptable number of patients who are malnourished but overestimates patients at moderate risk.

Adult↗

PubMed2005

Validating task analysis for error identification: reliability and validity of a human error prediction technique.

This paper reports on the theoretical and empirical developments for an error prediction methodology called task analysis for error identification (TAFEI). Other researchers have noted the need for theoretically driven approaches that are able to provide practical utility in error prediction. Theoretical developments include the concept of "rewritable routines", which describe the loop between cognitive processing, action and devices states. This has been proposed as a way of unifying ideas from systems theory and cognitive psychology. The empirical research shows that TAFEI is superior to heuristic methods, which supports the idea that structured methods assist in error prediction. The validation study shows that TAFEI reaches acceptable levels in terms of test-retest reliability and concurrent validity. It is believed that the method has reached a level of maturity after 10 years of development work. This is demonstrated by the many uses to which the method has been put, including that of a design tool.

Adult↗